BlackRock Inc., 1 of the world’s largest hedge funds, boosted its stake in a clutch of medical device companies, with 1 exception.
The New York-based firm increased its position in St. Jude Medical (NYSE:STJ), Sirona Dental Systems (NSDQ:SIRO) and Boston Scientific (NYSE:BSX) by double-digit percentages, according to regulatory filings. With other companies, the stakes seem to be newly acquired as of the end of 2012.
BlackRock, which has more than $3.51 trillion in assets under its umbrella, raised its share in St. Jude by more than 26%, owning about 19.6 million shares. Next up was Sirona, with a share boost of 19.5%, followed by Boston Scientific, with a 13.5% increase.
Notable new positions include Becton Dickinson & Co. (NYSE:BDX), Covidien (NYSE:COV) and Edwards Lifesciences (NYSE:EW). The lone exception to the buying spree was Varian Medical (NYSE:VAR); BlackRock pared its stake there by 1.1%, to roughly 5.5 million shares.
Here’s a look at the investments, with "n/a" denoting a new position:
|Becton Dickinson & Co. (NYSE:BDX)||10.3 million||5.2%||n/a|
|Boston Scientific (NYSE:BSX)||84.0 million||6.1%||13.5%|
|C.R. Bard (NYSE:BCR)||4.2 million||5.2%||5.2%|
|Covidien (NYSE:COV)||23.7 million||5.0%||n/a|
|DexCom Inc. (NSDQ:DXCM)||3.6 million||5.2%||7.6%|
|Edwards Lifesciences (NYSE:EW)||6.5 million||5.6%||n/a|
|Endologix (NSDQ:ELGX)||3.1 million||5.1%||8.7%|
|Grifols (NSDQ:GRFS)||11.0 million||5.2%||n/a|
|Hospira (NYSE:HSP)||10.5 million||6.4%||n/a|
|Mako Surgical (NSDQ:MAKO)||2.5 million||5.4%||n/a|
|Philips (NYSE:PHG)||48.7 million||5.1%||n/a|
|Sirona Dental Systems (NSDQ:SIRO)||3.3 million||6.0%||19.5%|
|St. Jude Medical (NYSE:STJ)||19.6 million||6.4%||26.1%|
|Varian Medical (NYSE:VAR)||5.5 million||5.0%||-1.1%|